La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Compumedics Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Compumedics.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Medical Equipment croissance des bénéfices | 16.0% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | None |
Dernière mise à jour | n/a |
Mises à jour récentes de la croissance future
Recent updates
Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce
Jun 17Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)
Mar 07We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt
Nov 03Is Compumedics (ASX:CMP) A Risky Investment?
May 27Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company
Jan 25Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year
Oct 19Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly
Oct 14Is Compumedics (ASX:CMP) Using Debt Sensibly?
May 02Compumedics (ASX:CMP) May Have Issues Allocating Its Capital
Dec 08Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends
Aug 09Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden
Jun 10Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)
May 06These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively
Feb 25How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?
Dec 01Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Compumedics n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.
Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2023 | 50 | 1 | -1 | 2 | N/A |
9/30/2023 | 47 | -2 | -3 | 1 | N/A |
6/30/2023 | 43 | -6 | -4 | 0 | N/A |
3/31/2023 | 42 | -6 | -3 | 1 | N/A |
12/31/2022 | 41 | -6 | -2 | 2 | N/A |
9/30/2022 | 40 | -2 | -1 | 2 | N/A |
6/30/2022 | 39 | 1 | 0 | 3 | N/A |
3/31/2022 | 37 | 1 | 0 | 3 | N/A |
12/31/2021 | 34 | 0 | 0 | 2 | N/A |
9/30/2021 | 35 | 0 | 0 | 2 | N/A |
6/30/2021 | 36 | 1 | 0 | 1 | N/A |
3/31/2021 | 35 | -2 | 1 | 2 | N/A |
12/31/2020 | 35 | -5 | 2 | 4 | N/A |
9/30/2020 | 35 | -5 | 1 | 4 | N/A |
6/30/2020 | 35 | -6 | 1 | 5 | N/A |
3/31/2020 | 38 | -1 | 0 | 5 | N/A |
12/31/2019 | 41 | 3 | -1 | 5 | N/A |
9/30/2019 | 41 | 4 | 0 | 5 | N/A |
6/30/2019 | 42 | 4 | 1 | 5 | N/A |
3/31/2019 | 41 | 3 | 1 | 4 | N/A |
12/31/2018 | 40 | 3 | 0 | 3 | N/A |
9/30/2018 | 38 | 3 | -1 | 2 | N/A |
6/30/2018 | 37 | 3 | -1 | 1 | N/A |
3/31/2018 | 36 | 2 | -2 | 0 | N/A |
12/31/2017 | 34 | 2 | -3 | -1 | N/A |
9/30/2017 | 34 | 2 | N/A | 0 | N/A |
6/30/2017 | 34 | 1 | N/A | 1 | N/A |
3/31/2017 | 35 | 1 | N/A | 2 | N/A |
12/31/2016 | 36 | 2 | N/A | 4 | N/A |
9/30/2016 | 37 | 2 | N/A | 3 | N/A |
6/30/2016 | 38 | 3 | N/A | 2 | N/A |
3/31/2016 | 36 | 3 | N/A | 2 | N/A |
12/31/2015 | 35 | 3 | N/A | 1 | N/A |
9/30/2015 | 34 | 2 | N/A | 2 | N/A |
6/30/2015 | 33 | 2 | N/A | 2 | N/A |
3/31/2015 | 33 | 2 | N/A | 1 | N/A |
12/31/2014 | 32 | 1 | N/A | 0 | N/A |
9/30/2014 | 31 | 1 | N/A | 1 | N/A |
6/30/2014 | 31 | 1 | N/A | 1 | N/A |
3/31/2014 | 30 | 0 | N/A | 1 | N/A |
12/31/2013 | 28 | 0 | N/A | 1 | N/A |
9/30/2013 | 28 | -1 | N/A | 1 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if CMP's forecast earnings growth is above the savings rate (2.4%).
Bénéfices vs marché: Insufficient data to determine if CMP's earnings are forecast to grow faster than the Australian market
Croissance élevée des bénéfices: Insufficient data to determine if CMP's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if CMP's revenue is forecast to grow faster than the Australian market.
Croissance élevée des revenus: Insufficient data to determine if CMP's revenue is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if CMP's Return on Equity is forecast to be high in 3 years time